CapsoVision, Inc 8K

CapsoVision, Inc. established a $100 million at-the-market equity offering program with Cantor Fitzgerald & Co. under a Sales Agreement dated August 13, 2026.

CapsoVision, Inc. entered into a Controlled Equity Offering Sales Agreement dated August 13, 2026, with Cantor Fitzgerald & Co., under which CapsoVision may, from time to time, issue and sell up to an aggregate of $100 million of its common stock through Cantor as sales agent or principal in one or more at-the-market offerings pursuant to a Form S-3 shelf registration statement and related prospectus supplement. The agreement specifies procedures for initiating and suspending sales via placement notices, settlement mechanics through DTC (DWAC), limitations tied to the number of registered and authorized shares and Form S-3 capacity, compensation to Cantor, and extensive company representations and warranties regarding its SEC filings, stock exchange compliance, financial statements, capitalization, regulatory and intellectual property status, and other customary conditions for such an equity distribution program.

Filing Facts

CIK

1378325

Ticker

-

Form

8K

Source Type

sec

Accession

0001378325-26-000035

Alert Tier

7